The Task-force in Europe for Drug Development for the Young (TEDDY) is a Network of Excellence (NoE)  funded in 2005 as a consortium responding to a call published by the European Commission and aimed at “structuring efforts devoted to the development of medicines tailored for children”.

Between 2005-2010, the FP6 TEDDY project (LSHB-CT-2005-005216) played a critical role in the start-up of paediatric activities in Europe, in parallel with the introduction of the new European Paediatric Regulation.

Since 2010 TEDDY has revised its organisation and gathered research centres and groups willing to be engaged in developing clinical research. Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from 15 countries aimed at facilitating the performance of good quality paediatric studies and research.

TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.

Latest News

505, 2017

European Parliament resolution of 15 December 2016 on the regulation on paediatric medicines

In December 2016, the European Parliament adopted a Resolution on the Regulation on Paediatric Medicines. TEDDY has contributed to it in providing some suggestions and comments in the drafting phase. The document acknowledges

1904, 2017

Save the date – International Paediatric Clinical Trial Day. “Helping children create lives they deserve”. Ospedale San Raffaele, Milan (Italy), May 9th, 2017.

On May 9th, 2017, the Italian Association of Contract Research Organizations (AICRO) will Organize in Milan, at the San Raffaele Hospital, the International Pediatric Clinical Trial Day Entitled "Helping children create lives